CHRISTOPHER MONDELLO: Open Payments
NPI 1598761124 · DUNDEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 51 payments from 17 companies in 2025. Trend: 2023 $2,606 · 2024 $2,021 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $179 |
| GlaxoSmithKline, LLC. | 7 | $130 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $86 |
| Phathom Pharmaceuticals, Inc. | 4 | $74 |
| Lundbeck LLC | 2 | $60 |
| Astellas Pharma US Inc | 2 | $59 |
| Exact Sciences Corporation | 2 | $53 |
| Lilly USA, LLC | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
Products named: TRELEGY ELLIPTA, VOQUEZNA, XIFAXAN, Ozempic, REXULTI, Veozah, Wegovy, MOUNJARO.
Industry payments across FL — which companies pay providers there.
